Documentation remains one of the most persistent weaknesses identified during U.S. Food and Drug Administration (FDA) inspections. Manufacturers may have missing, incomplete, outdated, or poorly executed procedures, and FDA's revised Pre-Approval Inspection (PAI) program increases the importance of resolving those gaps before an application reaches inspection. Facility teams must be able to show that the right documentation exists, reflects current operations, and supports the commitments made in the regulatory submission.
Engineering has one set of records. Quality maintains another. Manufacturing owns operating procedures. Project teams manage turnover documentation. Vendors contribute manuals, certifications, and test reports. Individually, each document may be complete. Collectively, they often lack the structure, ownership, and traceability needed to demonstrate that a facility is truly ready for commercial manufacturing.
That distinction is becoming increasingly important.
The FDA's recently announced enhancements to its Pre-Approval Inspection (PAI) program signal a broader shift in how the agency evaluates manufacturing readiness. While the fundamentals of current Good Manufacturing Practice (cGMP) compliance have not changed, FDA is placing greater emphasis on integrated assessments, risk-based inspections, remote document review, and confirming that what was promised in a regulatory submission matches what exists on the manufacturing floor.
For manufacturers preparing new product introductions, expanding facilities, or bringing new production lines online, this is more than an inspection update. It's a reminder that readiness is demonstrated long before an investigator arrives.
The Inspection Starts Before the Inspection
Traditionally, many organizations viewed a Pre-Approval Inspection as the final hurdle before commercialization. Documentation was assembled, teams rehearsed responses, and attention shifted toward preparing for the inspection itself.
FDA's revised approach reinforces a different reality.
Inspectors increasingly begin evaluating a facility before they arrive on site. Remote record requests, risk-based planning, and integrated quality assessments allow investigators to identify potential concerns earlier in the process. By the time an inspection begins, FDA often has a clear understanding of where it wants to focus its attention.
That changes the conversation.
Success is no longer measured by how efficiently documents can be gathered during an inspection. It's measured by whether the organization's documentation, quality systems, manufacturing operations, and regulatory commitments already align.
Documentation Is Only Part of the Story
Most manufacturers have invested heavily in document management systems. They maintain validated electronic repositories, controlled procedures, and established document control processes.
Those systems remain essential.
But document management alone does not ensure documentation governance.
A facility can have every required document and still struggle to demonstrate how those documents connect across the lifecycle of a project.
Consider a typical capital expansion.
Engineering develops design documentation. Procurement manages vendor deliverables. Construction creates turnover packages. Quality develops procedures. Manufacturing prepares operating instructions. Validation generates supporting evidence. Operations ultimately inherits thousands of documents produced by multiple organizations over several years.
Each group fulfills its responsibilities.
Yet no one may be responsible for ensuring the entire documentation ecosystem works together.
That gap becomes visible during inspections.
FDA is not reviewing records in isolation. Investigators use them to assess whether the facility is ready for commercial manufacturing, whether its processes and controls support product quality, whether site operations match the application, and whether the underlying data are reliable.
In other words, they're evaluating the integrity of the system behind the documents.
Readiness Begins Long Before Startup
One of the most common misconceptions in capital projects is that documentation is something to organize near project completion.
In reality, documentation strategy should begin during project planning.
When documentation requirements, ownership, review workflows, and turnover expectations are established early, projects move more efficiently. Teams spend less time searching for information, resolving inconsistencies, or recreating missing records during startup.
More importantly, operational teams receive documentation that supports long-term manufacturing rather than simply satisfying project closeout.
Organizations that establish documentation expectations early are often better positioned to support technology transfer, process validation, training, change management, and regulatory inspections because the information already exists within a structured framework.
The Real Challenge Is Documentation Governance
The FDA's updated inspection approach reinforces, rather than replaces, its long-standing expectations for documentation.
Manufacturers must be able to show that quality systems, manufacturing operations, engineering decisions, and regulatory commitments work together as one integrated system. Achieving that level of alignment is not simply a document-control issue. It is a governance challenge.
Most organizations have processes for creating, reviewing, approving, and storing documents. Fewer have a consistent framework for deciding what documentation is required, who owns it, how requirements flow across functions, and how records support the full project and asset lifecycle.
- What documentation is actually required?
- Who owns it?
- When should it be created?
- How does it support downstream activities?
- How is traceability maintained throughout the project lifecycle?
- How is documentation transferred into operations?
Without clear answers, documentation becomes fragmented across departments, contractors, vendors, and project phases. The result is unnecessary risk, delayed turnover, inconsistent information, and increased effort during inspections.
A Different Way to Think About Documentation
At Hygenix, we've seen this challenge across capital projects, facility expansions, technology transfers, and operational readiness initiatives.
The issue is rarely that organizations don't create enough documentation. The issue is that documentation is rarely governed as a strategic business asset.
That's why Hygenix developed Documentation Master Planning (DocMP).
Rather than focusing on collecting documents at the end of a project, DocMP establishes a governance framework before work begins. It defines documentation requirements, ownership, lifecycle expectations, traceability, and information flow across engineering, quality, manufacturing, procurement, and operations. The objective is to create documentation that supports the entire facility lifecycle, not just project turnover.
When documentation is governed from the beginning, inspections become a confirmation of operational maturity rather than a scramble to assemble evidence.
FDA Expects More. Shouldn't Your Documentation Strategy?
FDA's updated Pre-Approval Inspection program sends a clear message.
The agency expects manufacturers to demonstrate that documentation, manufacturing processes, quality systems, and regulatory commitments are aligned, reinforcing a long-standing standard that well-prepared organizations have consistently met.
The organizations that respond proactively won't wait until inspection planning begins. They'll evaluate how documentation is defined, managed, transferred, and governed across the entire project lifecycle.
Because when documentation governance is established early, inspections become easier, project turnover becomes smoother, and operational readiness becomes more predictable.
Is Your Documentation Strategy Ready for What's Next?
If you're planning a facility expansion, preparing for a new product introduction, or managing a major capital project, ask yourself one question:
Could your organization clearly demonstrate how every critical document supports your manufacturing process from project planning through commercial operations?
If the answer isn't an immediate yes, the challenge may not be document control. It may be documentation governance.
Hygenix helps manufacturers build that foundation before documentation gaps become project delays, operational inefficiencies, or regulatory concerns. Through DocMP, we help organizations establish a structured governance strategy that improves project execution, supports operational readiness, and strengthens long-term compliance confidence.
If you're ready to move beyond managing documents and start governing them, let's start the conversation.